ArticleRadiation oncology (London, England)2026
CBCT based online daily adaptive treatment improves target coverage with limited benefit for OAR protection in SBRT prostate cancer.
Ádám Gáldi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.